Call for Abstract
10th International Conference on Clinical & Experimental Ophthalmology, will be organized around the theme “Insights of Ophthalmology ”
Ophthalmology 2016 is comprised of 16 tracks and 96 sessions designed to offer comprehensive sessions that address current issues in Ophthalmology 2016.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Clinical Ophthalmology will enhance your knowledge of common ocular diseases, ophthalmic surgical and laser procedures, clinical anatomy and ocular therapeutics. You will develop analytical skills for solving clinical case problems and evaluating published research, and gain valuable research experience through the opportunity.
- Track 1-1Ocular Refraction and Therapeutics
- Track 1-2Community Ophthalmology
- Track 1-3Eye and Sorroundings Disorders
The retina is a thin layer of tissue on the inside back wall of your eye. It contains millions of light-sensitive cells and other nerve cells that receive and organize visual information. Your retina sends this information to your brain through your optic nerve, enabling you to see. Retinal degenerative disorders such as Age-related macular degeneration and Myopic macular degeneration affecting young and old from many cultures, races and ethnicities. The central area of the retina contains a high density of color-sensitive photoreceptor cells called cones which are responsible for color vision and hence any defect and alteration in the central area of the retina will lead to Color vision defects. On the other hand diseases like Diabetic retinopathy and Retinal tumors can also be responsible for the permanent vision loss if it is not treated on time. Historically, retinal disease has had a low priority in prevention of blindness programs in developing countries. There are several reasons for this. Firstly, it was thought that retinal disease was an uncommon cause of blindness in the developing world; secondly, that the results of treating retinal disease did not justify the effort and expense involved; and, thirdly, that the equipment required was too costly and unreliable for use in a developing country environment. Finally, there is a lack of skilled personnel with sub-specialty training in retinal disease. John Hopkins School of Medicine, UCSF School of Medicine, David Geffen School of Medicine and Mayo Medical School are the leading institutes associates with ophthalmology.
- Track 2-1Age-related macular degeneration
- Track 2-2Choroidal Neovascularization
- Track 2-3Hemoglobinopathy Retinopathy
- Track 2-4Retinal detachment
- Track 2-5Retinal vein occlusion
- Track 2-6Retinal artery occlusion
- Track 2-7Retinal tumors
- Track 2-8Color vision defects
- Track 2-9Diabetic retinopathy
- Track 2-10Myopic macular degeneration
- Track 2-11Retinopathy of Prematurity Ophthalmologic Approach
Pediatric ophthalmology is a sub-speciality of ophthalmology concerned with eye diseases, visual development, and vision care in children. The pediatric ophthalmologist has additional training, experience, and expertise in examining children, and has the greatest knowledge of possible conditions that affect the pediatric patient and his/her eyes. Neurologic development of vision occurs up until approximately age 12 years. Misalignment of the eyes (strabismus), uncorrected refractive error (myopia, hyperopia, and astigmatism), and asymmetry of refractive error between the two eyes can negatively affect this development. If these conditions are diagnosed and treated early, good vision can develop and can be maintained. Certain diseases elsewhere in the body, such as diabetes, can affect the eyes, and the pediatric ophthalmologist addresses these, as well.
- Track 3-1Retinopathy of Prematurity
- Track 3-2Eye screening
- Track 3-3Strabismus
- Track 3-4Amblyopia, Exotropia, Esotropia
- Track 3-5Superior Oblique Palsy
- Track 3-6Retinoblastoma
- Track 3-7Thyroid Eye Disease
- Track 3-8Orbital Trauma
It is a practice of an ophthalmologists, researchers and scientist to deal with the various eye health issues with an aim to treat the illness.
- Track 4-1Ophthalmology Practice Management
- Track 4-2Ophthalmology Practice Management Software
Translational Ophthalmology is a latest trend that bridges the gap by achieving breakthrough discoveries to patients faster than ever. Translational Research is a new initiative of the National Institutes of Health (NIH) which aims to translate basic research into more advanced form to yield the better results. The research trend discoveries maximize the opportunities to investigate the issues very minutely to decrease the risk of failure especially during surgical procedure like cataract and refractive surgery. Many fruitful facts have been discovered which indirectly helps in treating the respective conditions such as Age-Related Eye Disease Study (AREDS) proved that nutritional supplements (nutrition and ophthalmology) could minimize the risk of AMD. The American Health Assistance Foundation, dedicated to eradicating age-related degenerative diseases, estimates that up to 11 million people in the United States have some form of AMD - a number expected to double by 2050. Estimates of the global cost of visual impairment AMD causes are $343 billion, including $255 billion in direct health care costs, according to the foundation. Ophthalmology represents 18 percent of the average case volume in surgery centers, second behind GI/endoscopy (25 percent). The average surgery center performs 4,869 cases annually, which would average to around 876 ophthalmology cases annually, according to VMG Health's 2009 Intellimarker.
- Track 5-1Strabismus Surgery
- Track 5-2Glaucoma Surgery
- Track 5-3Cataract and Refractive Surgery
- Track 5-4Retinal Detachment Surgery
- Track 5-5Vision Correction Surgery
- Track 5-6Ophthalmology Surgical Instruments
- Track 5-7Eye Surgery Updates
- Track 5-8Oculoplastic Surgery
Optometry is a health care profession concerned with the health of the eyes and related structures, as well as vision, visual systems, and vision information processing in humans.
Basic research in Vision Science focuses on such disciplines as bioengineering, psychophysics, neurophysiology, visual neuroscience, molecular and cell biology, cell membrane biochemistry, biostatistics, robotics, contact lenses, spatial navigation, ocular infections, refractive development, corneal surface mapping, infant vision, computational vision, and 3D computer modeling.
- Track 6-1Optics and applied vision research
- Track 6-2Vision Therapy
- Track 6-3Binocular Disorders
- Track 6-4Eye Implants
- Track 6-5Optometry Therapeutics
- Track 6-6Optician
- Track 6-7Contact lenses & vision correction
- Track 6-8Low vision & Color vision
- Track 6-9Astigmatism
Eye is composed of very sensitive and fragile tissues and every part of an eye serves its own function to maintain its normal vision. The cornea is the transparent front part of the eye that covers the iris, pupil, and anterior chamber. The cornea, with the anterior chamber and lens, refracts light, with the cornea accounting for approximately two-thirds of the eye's total optical power. But factors such as corneal ulceration, Epithelial keratitis & drug-induced epithelial keratitis, corneal regeneration, recurrent corneal erosion and miscellaneous corneal disorders can affect the cornea and ultimately lead to the external eye disease that could end up with permanent blindness. Hence investigation of corneal disease is carry out to mitigate the disease and methods like Contact lenses & vision correction is also use to cure the vision related problems and surgical procedure like corneal transplantation is used to transplant the cornea.
- Track 7-1Investigation of corneal disease
- Track 7-2Corneal ulceration
- Track 7-3Epithelial keratitis & drug-induced epithelial keratitis
- Track 7-4Corneal degeneration
- Track 7-5Recurrent corneal erosion
- Track 7-6Corneal transplantation
- Track 7-7Miscellaneous corneal disorders
- Track 7-8Corneal neovascularization
Neuro-ophthalmology is the incorporation of neurology and ophthalmology, often dealing with complex systemic diseases that have manifestations in the visual system. Cerebral Visual Impairment (CVI) includes all visual dysfunctions caused by damage to, or malfunctioning of, the retrochiasmatic visual pathways in the absence of damage to the anterior visual pathways or any major ocular disease. Myasthenia gravis is caused by a breakdown in the normal communication between nerves and muscles which leads to double vision, drooping eyelids and other muscles weakness which effecting the both i.e. neuromuscular activity and also vision. On the other hand nystagmus which is involuntary eye movement acquired in infancy or later in life that may result in reduced or limited vision. Factors like cerebral macular degeneration and chronic progressive external ophthalmoplegia also the major effecting part of neuro-ophthalmology. Diagnostic tools in neuro-ophthalmology are used to investigate and to treat the various condition of neuro-ophthalmology as Neonatal ocular examination are primarily performed to monitor the presence and progression of Retinopathy of Prematurity. University of Pennsylvania is currently working on neuro-ophthalmology project.
- Track 8-1Retrochiasmatic visual pathways
- Track 8-2Myasthenia gravis
- Track 8-3Chronic progressive external ophthalmoplegia
- Track 8-4Cerebromacular degeneration
Glaucoma is a multifactorial optic neuropathy that affects more than 50 million people and is the second leading cause of blindness worldwide. The role of intra ocular pressure (IOP) has been well documented as a major modifiable risk factor for glaucoma. Additionally, many glaucoma patients have a relatively low IOP, while some healthy individuals have a relatively high IOP. The disorders can be roughly divided into two main categories, open-angle glaucoma and closed-angle glaucoma. Impaired ocular blood flow regulation in open angle glaucoma as a risk of glaucoma has also been well established, especially over the past two decades. Pathophysiology of glaucoma indicates towards the increased in intraocular pressure which compresses and damages the optic nerve. Once the optic nerve is damaged, it fails to carry visual information to the brain and this result in loss of vision. The exact pathophysiology of glaucoma contributing to this is yet to be determined. Biomarkers for glaucoma have predictive use that could help and guide more specific therapy in some glaucoma patients. Endothelin in glaucoma treatment play a very key role in pathogenesis of glaucoma. Glaucoma accounts for over 10 million visits to physicians each year. In terms of Social Security benefits, lost income tax revenues, and health care expenditures, the cost to the U.S. government is estimated to be over $1.5 billion annually. The Glaucoma Research Society of Canada is the only Canadian non-profit organization solely dedicated to funding glaucoma research. Since 1989, it has raised more than two million dollars in support of 150 research projects. The Society funds 10 to 15% of all independent glaucoma research in Canada. Bascom Palmer and Wills Eye are the top researcher organization for glaucoma.
- Track 9-1Pathophysiology of glaucoma
- Track 9-2Open-angle glaucoma
- Track 9-3Biomarkers for glaucoma
- Track 9-4Impaired ocular blood flow regulation in open angle glaucoma
- Track 9-5Endothelin in glaucoma treatment
- Track 9-6Complications and Management of Glaucoma Filtering
- Track 9-7Closed-angle glaucoma
Orthoptics is a discipline dealing with the diagnosis and treatment of defective eye movement and coordination (such as nystagmus), binocular vision, and amblyopia by eye care professionals.
There are five areas of treatment for orthoptic problems:
- Corrective lenses (spherical, cylindrical lens, prismatic and Fresnel lenses)
- Strabismic-related orthoptics as an "eye exercise" is limited to the treatment of eye coordination problems by increasing the range of binocular fusion.
- Pharmaceuticals, such as cycloplegics
- Track 10-1A-Pattern Esotropia and Exotropia
- Track 10-2Internuclear ophthalmoparesis
- Track 10-3Squint management devices
- Track 10-4Esotropia with High AC/A Ratio
- Track 10-5Convergence Insufficiency
- Track 10-6Congenital Nystagmus
- Track 10-7Congenital Exotropia
- Track 10-8Accommodative Esotropia
- Track 10-9Abducens Nerve Palsy
- Track 10-10Vision screening
- Track 10-11Ocular motility diagnosis & co-management
Many of the viruses, bacteria, parasites, and fungi that can invade the human body are also capable of attacking the surface or interior of the eye. The natural tendency for immunologic disease to affect the eye derives from a number of factors such as Antibody-dependent & antibody-mediated diseases, Uveitis, intraocular inflammation and cell-mediated diseases. The immune system plays a critical role during transplantation and as the corneal transplantation has become increasingly common since the 1960s and over 40,000 transplants were performed in 1990 in the United States and Canada. The 5-year failure rate for corneal grafts is approximately 35%; corneal graft rejection is the most common cause of graft failure in the late postoperative period but with the recent development in immunotherapy can be a breakthrough to overcome from all the limitations of the conventional procedures. The microbiological infection such as fungal endophthalmitis can affect the vitreous and anterior chamber of the eye and hence the uses of antibiotic in ocular infections have been increased to overcome these conditions. The consumables, equipment and technology markets in the microbiology industry totaled nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.
- Track 11-1Antibody-dependent & antibody-mediated diseases
- Track 11-2Cell-mediated diseases
- Track 11-3Corneal graft reactions
- Track 11-4Fungal endophthalmitis
- Track 11-5Antibiotics in ocular infections
- Track 11-6Uveitis, intraocular inflammation
- Track 11-7Recent developments in immunotherapy
Systems to deliver medication predictably over time are not new to Ophthalmology. The novel research refers to approaches, formulations, technologies and systems to achieve the desired therapeutic effect. The novel approach is applicable to Anti IL-6 therapy, Therapies in fighting blindness, translational research for periocular basal cell carcinoma and sebaceous cell carcinoma and updates in management of thyroid eye disease. Conditions like corneal reshaping & transplantation, choroidal imaging corneal neovascularization can be treated by using novel vision correction procedures. The average gross charges for ophthalmology cases performed in the ASC (Ambulatory Surgery Center) are $5,385. The average case revenue is $1,226, according to VMG Health's 2009 Intellimarker. Charles River, Ora, CombinatoRx and Fovea Pharmaceuticals working to introduced novel approaches in ophthalmic research.
- Track 12-1Anti IL-6 therapy
- Track 12-2Corneal reshaping & transplantation
- Track 12-3Choroidal imaging
- Track 12-4Therapies in fighting blindness
- Track 12-5Translational research for periocular basal cell carcinoma and sebaceous cell carcinoma
- Track 12-6Impact of possitron emission tomography in ocular adnexae lymphoma
- Track 12-7Updates in management of thyroid eye disease
- Track 12-8Genetic Eye Disease
Advances in ophthalmic drug delivery systems such as Punctal Plugs, Ocular Therapeutix, Mati therapeutics (QLT) and gel-forming drops can be breakthrough in ophthalmic research and advance drug delivery system to maximize the therapeutic effect of a particular drug. Topical combination of corticosteroid & anti-infective agents, Drugs used in the treatment of allergic conjunctivitis, Oral & topical nonsteroidal anti-inflammatory agents (NSAIDs) and Retinoblastoma chemotherapy are few developed formulation to treat ophthalmic diseases. Companies like Allergan, Pfizer, Bausch + Lomb, Merck & Co. and Regeneron are actively participated in ophthalmic research and drug development. According to visiongain (Ophthalmic Drugs: World Market Prospects - 2013-2023; October 2013), the worldwide ophthalmic market was $17.5 billion in 2011 and is expected to grow to $34.7 billion by 2023, representing a 5.9% compounded annual growth rate.
- Track 13-1Advances in ophthalmic drug delivery systems
- Track 13-2Extended activity approaches
- Track 13-3IVT injection-sparing approaches
- Track 13-4Ocular & systemic side effects of drugs
- Track 13-5Diagnostic dye solutions
- Track 13-6Oral & topical nonsteroidal anti-inflammatory agents (NSAIDs)
- Track 13-7Drugs used in the treatment of allergic conjunctivitis
- Track 13-8Transplantation technologies for retina
- Track 13-9Topical combination corticosteroid & anti-infective agents
- Track 13-10Sustained delivery approaches
A global platform aimed to connect ophthalmic industries, Proposers, Entrepreneurs and the Investors worldwide. With a vision to provide and facilitate the most efficient and viable business meeting place for engaging people in constructive discussions, evaluation and execution for a promising future in the field of ophthalmology.